Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -164,076 | -118,961 | -276,056 | -368,198 | -523,837 |
| Depreciation Amortization | 1,026 | 4,391 | 84,316 | 13,030 | 14,146 |
| Income taxes - deferred | N/A | N/A | N/A | 2,708 | -102 |
| Accounts receivable | N/A | -3,045 | 4,776 | 16,511 | 12,397 |
| Accounts payable and accrued liabilities | -625 | 2,668 | -2,884 | 3,103 | -11,690 |
| Other Working Capital | -37,016 | -6,239 | -19,940 | 492 | -22,974 |
| Other Operating Activity | -7,820 | -54,523 | 17,182 | 28,347 | 119,400 |
| Operating Cash Flow | $-208,511 | $-175,709 | $-192,606 | $-304,007 | $-412,660 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -329 | 78,652 | N/A | N/A | N/A |
| PPE Investments | -171 | -1,468 | 380 | 7,520 | -14,989 |
| Net Acquisitions | -697 | 65,386 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -511,699 | -467,914 | -960,689 |
| Sale Of Investment | N/A | N/A | 650,883 | 826,229 | 1,178,455 |
| Investing Cash Flow | $-1,197 | $142,570 | $139,564 | $365,835 | $202,777 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 181,716 | 30,118 | 30 | 758 | 33,238 |
| Common Stock Repurchased | N/A | -3,000 | N/A | N/A | N/A |
| Other Financing Activity | -1,150 | 15,000 | 0 | 750 | 3,000 |
| Financing Cash Flow | $180,566 | $42,118 | $30 | $1,508 | $36,238 |
| Exchange Rate Effect | 6 | -4 | 62 | -327 | -92 |
| Beginning Cash Position | 44,252 | 35,277 | 88,227 | 25,218 | 198,955 |
| End Cash Position | 15,116 | 44,252 | 35,277 | 88,227 | 25,218 |
| Net Cash Flow | $-29,136 | $8,975 | $-52,950 | $63,009 | $-173,737 |
| Free Cash Flow | |||||
| Operating Cash Flow | -208,511 | -175,709 | -192,606 | -304,007 | -412,660 |
| Capital Expenditure | -171 | -1,468 | -865 | -5,676 | -14,989 |
| Free Cash Flow | -208,682 | -177,177 | -193,471 | -309,683 | -427,649 |